Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative diquafosol sodium for ocular surface protection in vitrectomy for diabetic retinopathy
ChiCTR2300070172Phase 4Not yet recruiting
- Sponsor
- Xuzhou No. 1 People's Hospital
- Start
- Feb 2023
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of diquafosol and sodium hyaluronate in dry eye syndrome (DED) (2 arms), sponsored by Xuzhou No. 1 People's Hospital. Primary endpoint: OSDI questionnaire survey. Planned start Feb 2023; status: not yet recruiting.
02
Drugs
diquafosolsodium hyaluronate
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on ChiCTR2300070172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070172.